At a glance
- What the study gets you
- Health checks and monitoring — no treatment given
- Type of study
- Observational (no treatment given)
- Time in hospital
- In-person visits at study sites — visit count not specified by the sponsor
- Drug or intervention
- Not specified by the sponsor
- How long the study runs
- Study runs about 64 months (dates as stated)
- About the drug or intervention
- Not specified by the sponsor
- Patient visit burden
- Not specified by the sponsor
- Type of study
- Observing health over time
- Ages
- Not specified
- Who
- All
- Number of participants
- 48
- Started
- 2021-08-01
- Last checked
- 2025-04
Plain English Summary
What is this study?
- • Testing a new treatment for neonatal seizure
- • Clinical study - 48 participants
- • To optimise and evaluate a novel non-contact physiological monitoring system in the neonatal intensive care unit (NICU)
Who can take part?
- • Adults
- • Diagnosed with neonatal seizure
Where?
- • Cambridge - Addenbrookes Hospital
This is a simplified summary. Always discuss with your doctor before making any decisions.
About This Trial
To optimise and evaluate a novel non-contact physiological monitoring system in the neonatal intensive care unit (NICU)
More detail
To optimise and evaluate a novel non-contact physiological monitoring system in the neonatal intensive care unit (NICU)
How this trial compares with your answers
Answer 2 more questions to improve match
What we know so far
Still need:
- • Tell us your age for better matching
- • Tell us your sex for better matching
Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.
Eligibility at a Glance
Key info
- Age: Not specified
- Who can join: All genders
What the study is looking for
- ✓written informed parental consent
See the full criteria
Where Is This Study? (1 UK site)
Addenbrookes Hospital
Cambridge, United Kingdom
How to Get in Touch
kathryn beardsall
Sponsor contactCONTACT
